Navigation Links
Reportlinker Adds US Cystic Fibrosis Industry
Date:6/24/2010

THODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-3

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

II. A US MARKET REPORT

1. MARKET OVERIVEW II-1

A Global Fact Sheet on Cystic Fibrosis II-1

Current and Future Analysis II-1

Cystic Fibrosis: A Life-Limiting Genetic Disease II-1

Cystic Fibrosis Scenario in the US II-2

Narrowing Mortality in the US II-2

Median Survival Age (MSA) of Patients with CF in United States II-2

Caucasians at Greater Risk II-3

A Market with Huge Unmet Medical Needs II-3

Pulmozyme and TOBI Dominate CF Market II-3

Table 1: US Market for Cystic Fibrosis by Leading Drugs

(2008): Annual Sales in US$ Million for Pulmozyme and TOBI II-3

Genentech/Roche and Novartis Lead the Pack II-4

Other Potential Market Contenders II-4

Mega Deals for Niche Local Players II-4

2. CYSTIC FIBROSIS TREATMENT: AN OVERVIEW II-5

EXISTING TREATMENT OPTIONS FOR CYSTIC FIBROSIS II-5

A Quick Glance at Common Drugs for Cystic Fibrosis Management II-6

Analysis of Drugs Indicated for Management of Cystic Fibrosis II-7


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Reportlinker Adds Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
2. Reportlinker Adds China Patient Monitoring Market Outlook to 2016
3. Reportlinker Adds The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets
4. Reportlinker Adds China Cardiovascular Devices Market Outlook to 2016
5. Reportlinker Adds Medical Device Distributors - Europe
6. Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
7. Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry
8. Reportlinker Adds Global HIV Drugs industry
9. Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets
10. Reportlinker Adds Antifungal Drugs: Technologies and Global Markets
11. Reportlinker Adds The World Anesthesia Drug Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Nov. 24, 2014 Juno Therapeutics today ... Designation to the company,s JCAR015 chimeric antigen receptor ... of relapsed or refractory B-cell acute lymphoblastic leukemia ... Sloan Kettering Cancer Center, where Phase 1 clinical ... FDA,s action is important news for patients who ...
(Date:11/24/2014)... 2014  Marta Rendon, MD, founder of the Rendon Center ... , FL and international key opinion leader in dermatology, was one ... United States to attend the international Aesthetic Experts ... . Here, at this gathering of over 600 physicians from ... plastic surgery experts from Asia and ...
(Date:11/24/2014)... , Nov. 24, 2014  AiCure, an ... motion-sensing technology to monitor medication ingestion, has announced ... monitor and intervene with patients receiving medication as ... Fatal overdoses from prescription opiates have quadrupled in ... deaths per year than heroin, cocaine and benzodiazepines ...
Breaking Medicine Technology:Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3Can artificial intelligence solve the $55 billion problem of opioid abuse? 2
... well-tolerated with signs of durable,disease control in advanced ... /PRNewswire-FirstCall/ -- IDM,Pharma, Inc. today presented preliminary results ... trial (DC-MEL-202). The,results showed that UVIDEM was well ... response in patients with,progressive metastatic melanoma. , The ...
... trial presented at ENDO 2007 , ,- Regulatory approvals ... recruitment in Europe , ,MONTREAL, QUEBEC -- (MARKET WIRE) ... that 26-week data from,its first Phase 3 study testing ... ENDO, the 89th,annual meeting of the Endocrine Society. The ...
Cached Medicine Technology:IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5Theratechnologies: TH9507 Phase 3 Clinical Update 2Theratechnologies: TH9507 Phase 3 Clinical Update 3
(Date:11/26/2014)... November 26, 2014 The Deptford ... have launched a partnership designed to improve the ... congestive heart failure (CHF) patients in the South ... and Lourdes Cardiology team will help CHF patients ... protocols. This partnership pairs the Cardiac Recovery program ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Increasing ... stringent drug safety regulations are expected to be ... period. Growing prevalence of acute and chronic ailments ... for new drug development. Moreover, growing adverse drug ... the same has become the need of the ...
(Date:11/26/2014)... 26, 2014 German scientists say carbon-based ... can cause mesothelioma that looks and acts similar to ... article on the research. Click here to read ... for Toxicology and Experimental Medicine in Hannover injected 500 ... of the rats eventually developed mesothelioma , how ...
(Date:11/26/2014)... 26, 2014 The city of San ... is moving forward with a plan to recycle wastewater ... host Sharon Kleyne supports the San Diego plan as ... (TWM). According to Kleyne, by recycling water that San ... water could be greatly reduced. (Spagat, E, “San Diego ...
(Date:11/26/2014)... Loffler Companies has been selected as a 2014 ... information and news publication for resellers of imaging technology, ... Loffler has earned this prestigious award and the seventh ... honor the best and the brightest in the imaging ... chosen for their innovative marketing and sales programs, community ...
Breaking Medicine News(10 mins):Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 2Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 3Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2
... with sound advice may help them identify hearing loss ... therefore untreated. ,Hearing loss in children often remain ... and lead to deficiency in attending, difficulty in attending ... to the researcher Judith Gravel from The Children's Hospital ...
... Adjuvant chemotherapy with epirubicin and cyclophosphamide for early ... myeloid leukemia or Myelodysplastic syndrome. ,Recent study ... early breast cancer patients undergoing chemotherapy with higher ... have an increased risk of developing Acute myeloid ...
... Heidelberg in Mannheim, concludes that women appear to develop alcoholic ... that women become dependant on alcohol not as frequently as ... on the general alcohol consumption pattern if men and women. ... and before pregnancy. It might have adverse effects on the ...
... plays an important role in increasing death risk.// It is ... that can kill him. ,Depression had long been taken ... disease. Now the team of researchers from Washington University School ... rate variability is the prime cause for such a case. ...
... sterols might help to lower your "bad" LDL cholesterol ... been shown to block cholesterol's absorption, lower blood cholesterol ... intestines. , ,The study had 29 participants, all ... type 2 diabetes and were slightly overweight. Participants were ...
... popular form of ancient Indian exercise and meditation for the ... healing properties and is popularly used to relieve people of ... trauma and anxiety in patients with breast cancer., ... Yoga therapy treated over 400 patients with breast cancer with ...
Cached Medicine News:Health News:High-Dosage of Epirubicin and Cyclophosphamide may cause AML 2Health News:Yoga Can Be Good For Breast Cancer Patients 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: